摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-fluoro-1-(tetrahydrofuran-2-yl)-3-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione

中文名称
——
中文别名
——
英文名称
5-fluoro-1-(tetrahydrofuran-2-yl)-3-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione
英文别名
Hydroxymethyl tegafur;5-fluoro-3-(hydroxymethyl)-1-(oxolan-2-yl)pyrimidine-2,4-dione
5-fluoro-1-(tetrahydrofuran-2-yl)-3-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione化学式
CAS
——
化学式
C9H11FN2O4
mdl
——
分子量
230.196
InChiKey
JDDDDOBTZSUOHS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    70.1
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    替加氟 tegafur 17902-23-7 C8H9FN2O3 200.169
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    —— diethyl (5-fluoro-2,3-dihydro-3-(tetrahydrofuran-2-yl)-2,6-dioxopyrimidin-1(6H)-yl)methyl phosphate —— C13H20FN2O7P 366.283

反应信息

  • 作为反应物:
    描述:
    5-fluoro-1-(tetrahydrofuran-2-yl)-3-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione氯磷酸二乙酯吡啶4-二甲氨基吡啶 作用下, 以 二氯甲烷 为溶剂, 以65%的产率得到diethyl (5-fluoro-2,3-dihydro-3-(tetrahydrofuran-2-yl)-2,6-dioxopyrimidin-1(6H)-yl)methyl phosphate
    参考文献:
    名称:
    [EN] DERIVATIVES OF CHEMOTHERAPEUTIC AGENTS WITH A FORMALDEHYDE RELEASING MOEITY
    [FR] DERIVES D'AGENTS CHIMIOTHERAPEUTIQUES ET UTILISATIONS
    摘要:
    公开号:
    WO2005120577A3
  • 作为产物:
    描述:
    聚合甲醛替加氟 为溶剂, 反应 0.83h, 以83.5%的产率得到5-fluoro-1-(tetrahydrofuran-2-yl)-3-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione
    参考文献:
    名称:
    [EN] DERIVATIVES OF CHEMOTHERAPEUTIC AGENTS WITH A FORMALDEHYDE RELEASING MOEITY
    [FR] DERIVES D'AGENTS CHIMIOTHERAPEUTIQUES ET UTILISATIONS
    摘要:
    公开号:
    WO2005120577A3
点击查看最新优质反应信息

文献信息

  • Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety
    申请人:Nudelman Abraham
    公开号:US20070293517A1
    公开(公告)日:2007-12-20
    Novel conjugates of chemotherapeutic agents, which are designed so as to release formaldehyde or analogs thereof upon cleavage, processes of preparing same, pharmaceutical compositions containing same and methods utilizing same for treating medical conditions such as cancer, immune-mediated diseases, viral infections and diseases, bacterial infections and diseases, fungal infections and diseases, protozal infections and diseases and more, and particularly for treating such conditions which are characterized by drug resistance are provided.
  • [EN] NOVEL DERIVATIVES OF CHEMOTHERAPEUTIC AGENTS AND USES THEREOF<br/>[FR] DERIVES D'AGENTS CHIMIOTHERAPEUTIQUES ET UTILISATIONS
    申请人:UNIV RAMOT
    公开号:WO2005120577A2
    公开(公告)日:2005-12-22
    Novel conjugates of chemotherapeutic agents, which are designed so as to release formaldehyde or analogs thereof upon cleavage, processes of preparing same, pharmaceutical compositions containing same and methods utilizing same for treating medical conditions such as cancer, immune-mediated diseases, viral infections and diseases, bacterial infections and diseases, fungal infections and diseases, protozal infections and diseases and more, and particularly for treating such conditions which are characterized by drug resistance are provided.
  • [EN] DERIVATIVES OF CHEMOTHERAPEUTIC AGENTS WITH A FORMALDEHYDE RELEASING MOEITY<br/>[FR] DERIVES D'AGENTS CHIMIOTHERAPEUTIQUES ET UTILISATIONS
    申请人:UNIV RAMOT
    公开号:WO2005120577A3
    公开(公告)日:2006-08-31
查看更多